SAA2 and glioma: We then performed a multivariate Cox regression analysis, and the immune signature constructed using HLA-DQA2, HOXA3, and SAA2 was found to act as an independent prognostic factor for glioma patients with IDH1mt, with an HR of 1.203 (Table 2).